Lupus Nephritis and JAK Inhibitors: Updates and Insights

This chapter covers recent updates from ACR Convergence 2024 on lupus nephritis treatment guidelines, including new recommendations and a shift towards triple therapy. It also explores the potential of JAK inhibitors in treating underserved diseases and examines the impact of immunosuppressive drugs on vaccine responses.

Play episode from 39:03

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app